Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiative

Chronological Source Flow
Back

AI Fusion Summary

Trump announced a deal with Regeneron to cut drug prices for Medicaid patients and future prescriptions, including a $225 cholesterol drug. The agreement, part of a most‑favored‑nation strategy, also shields Regeneron from tariffs for three years, marking the 17th such pact.
23/04 23:39 wdrb.com
3 Πηγές
23/04 23:55 timesnownews.com
24/04 01:52 pbs.org
Comments
Loading...
0